A Blended Psychological Intervention for Depression After Acquired Brain Injury
NCT ID: NCT05788146
Last Updated: 2023-03-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2023-06-01
2024-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objective: Phase 1 of the study aims to investigate whether a blended psychological intervention, using a novel smartphone-based application alongside individual therapy sessions is acceptable and feasible for targeting depression after ABI. Phase 2 of the study aims to use qualitative interviews to better understand the participants' experiences of using the mobile app as part of the intervention.
Methodology: The researchers aim to recruit 20 individuals with ABI, who are experiencing mild-moderate symptoms of depression. Participants will complete outcome measures and cognitive tasks at the beginning of the study. Participants will then receive a six-week blended psychological intervention; engaging the CBT-based mobile app alongside weekly, 30-minute video or telephone sessions for therapeutic and technology support. Participants will then be asked to complete the same outcome measures as completed at the beginning of the study. Participants will then be invited to take part in a 30-minute interview about their experience of using the mobile app as part of the intervention.
Data Analysis: Change scores will be calculated from the data collected as part of phase 1 of the study, to investigate initial efficacy. Recruitment and dropout rates will help determine the feasibility of the blended intervention. In the 2nd phase, qualitative data will be analysed following Ritchie and Lewis (2003)'s Framework Analysis.
Findings: Results from this study will help increase understanding into the acceptability and feasibility of using mHealth technology for treating depression following ABI. If effective, it could help to increase access to psychological interventions for individuals living with ABI. We hope to publish findings in a peer reviewed journal.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Adapted Cognitive Behavioral Treatment for Depression in Patients With Moderate to Severe Traumatic Brain Injury
NCT03307070
Life Improvement Following Traumatic Brain Injury
NCT00878150
Internet-delivered Cognitive Behavioural Therapy for Persons With Stroke
NCT05243615
Treatment of Post-TBI Depression
NCT00211835
Internet-based CBT After Stroke Pilot
NCT03615079
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Blended psychological intervention
Cognitive Behavioural Therapy
A psychological intervention used to target depression
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive Behavioural Therapy
A psychological intervention used to target depression
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ABI occurring within the last 5 years.
* 18 years old or over.
* Fluency in English adequate enough to engage with the blended intervention.
* A score equal or greater than 5, but no more than 14 on the Brief Patient Health Questionnaire (PHQ-9), indicating mild-moderate levels of depression.
* Have access to an iOS or Android app-compatible smartphone for the duration of the study.
Exclusion Criteria
* Inability to consent to take part in the research study.
* Unable to undergo a verbal interview due to impairment of comprehension.
* A visual or auditory problem that cannot be corrected and would seriously interfere with participation in the research study.
* Currently in receipt of other individual psychological therapy
* Currently enrolled in another clinical trial or research study
* Have a reading ability or command of English language inadequate for engaging with the blended intervention.
* Diagnosed with a neurodegenerative disorder, e.g. dementia, Parkinson's disease etc.
* Active suicidal ideation (as indicated by a score ≥ 2 on item 9 of the PHQ.
* A score greater than or equal to 20 on the PHQ-9 which indicates a severe level of depression
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
King's College London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KCLGL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.